Stay updated on Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content and indicating an access/permissions issue. The surrounding site chrome remains visible, showing this is an error state rather than new study information.
    Difference
    23%
    Check dated 2026-09-20T11:26:29.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page's metadata or content, with no impact on study details.
    Difference
    0.0%
    Check dated 2026-08-29T23:47:24.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5. This reflects a minor update to the page metadata rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-08-08T23:21:56.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, indicating an update to the site's underlying system or documentation. No visible changes to the study details appear to be introduced by this change.
    Difference
    0.0%
    Check dated 2026-07-25T13:00:45.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous v3.6.2, indicating a backend or template update.
    Difference
    0.0%
    Check dated 2026-07-04T04:12:34.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The study page now references revision v3.6.2 for the protocol/SAP, replacing the previous v3.6.0. This signals a newer version of the study documentation is available for review on the page.
    Difference
    0.0%
    Check dated 2026-06-27T02:17:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.